Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC016324 | Panoply™ Human TMSB10 Knockdown Stable Cell Line | Inquiry |
| CSC-SC016324 | Panoply™ Human TMSB10 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1227 | Human TMSB10 Knockout Cell Line-HEK293T | Inquiry |
| CSC-RT1931 | TMSB10 Knockout Cell Line-HCT116 | Inquiry |
| CLKO-1080 | TMSB10 KO Cell Lysate-HEK293T | Inquiry |
| CLKO-1787 | TMSB10 KO Cell Lysate-HCT116 | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD16636Z | Human TMSB10 adenoviral particles | Inquiry |
| LV28271L | human TMSB10 (NM_021103) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH431560 | shRNA set against Rat TMSB10 (NM_021261.2) | Inquiry |
| SHH431552 | shRNA set against Human TMSB10 (NM_021103.3) | Inquiry |
| SHH431556 | shRNA set against Mouse TMSB10 (NM_025284.4) | Inquiry |
| SHL083142 | shRNA set against Rat Tmsb10(NM_021261.2) | Inquiry |
| SHL083196 | shRNA set against Human TMSB10(NM_021103.3) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCR378727 | Rat Tmsb10 ORF Clone(NM_021261.2) | Inquiry |
| CDCS415272 | Human TMSB10 ORF Clone (BC016731) | Inquiry |
| CDFG003206 | Human TMSB10 cDNA Clone(NM_021103.3) | Inquiry |
| CDFR011680 | Rat Tmsb10 cDNA Clone(NM_021261.2) | Inquiry |
| MiUTR1H-10581 | TMSB10 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-08108 | TMSB10 miRNA 3'UTR clone | Inquiry |
| SKO0848 | TMSB10 Validated sgRNA vector | Inquiry |
| CDCB188383 | Rabbit TMSB10 ORF clone (XM_002709679.2) | Inquiry |
| CDCG002783 | Mouse TMSB10 ORF clone(NM_001039392.2) | Inquiry |
| CDCR243057 | Mouse Tmsb10 ORF Clone(NM_001190327.1) | Inquiry |
| CDCR256605 | Mouse Tmsb10 ORF Clone(NM_025284.4) | Inquiry |
| CDCR306603 | Human TMSB10 ORF Clone(NM_021103.3) | Inquiry |
| CDCS415271 | Human TMSB10 ORF Clone (BC016025) | Inquiry |